CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- 4 Open-market sale Chief Scientific Officer sold 4,500 shares at an average $21.13 ($95,097)
- 4 Open-market sale Chief Scientific Officer sold 4,500 shares at an average $18.97 ($85,369)
- 4 Open-market sale President and CEO sold 15,714 shares at an average $18.55 ($291,474)
- 4 Open-market sale Chief Scientific Officer sold 4,500 shares at $22.97 ($103,350)
- 4 Open-market sale Chief Scientific Officer sold 4,500 shares at an average $21.21 ($95,464)
- 4 Open-market sale President and CEO sold 15,714 shares at $21.63 ($339,829)
- 4 Open-market sale Chief Scientific Officer sold 4,500 shares at $21.51 ($96,791)
- 4/A Grant or award Director acquired 55,555 shares (grant or award)
- 4 Open-market buy Director bought 55,555 shares at $18.00 ($999,990)
- 4 Open-market sale Chief Scientific Officer sold 4,500 shares at an average $22.32 ($100,439)
- 4 Open-market sale President and CEO sold 15,714 shares at $22.45 ($352,833)
- 4 Open-market sale Chief Scientific Officer sold 4,500 shares at $22.80 ($102,587)
- 4 Open-market sale Chief Scientific Officer sold 4,500 shares at $19.96 ($89,829)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion VP Finance & Operations acquired 3,481 shares (option exercise)
- 4 Open-market sale President and CEO sold 3,839 shares at $18.57 ($71,276)
Page 15 of 18 · 354 filings